慢性特発性便秘（CIC）治療薬の世界市場（～2026年）

• 英文タイトル：Global Chronic Idiopathic Constipation (CIC) Drugs Market Insights and Forecast to 2026

• レポートコード：MRC2-11QY00261 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、114ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,170,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料は慢性特発性便秘（CIC）治療薬のグローバル市場について調査・分析したレポートです。種類別（ルビプロストン、リナクロチド、その他）市場規模、用途別（病院・診療所、外来外科センター、介護センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別慢性特発性便秘（CIC）治療薬の競争状況、市場シェア ・世界の慢性特発性便秘（CIC）治療薬市場：種類別市場規模 2015年-2020年（ルビプロストン、リナクロチド、その他） ・世界の慢性特発性便秘（CIC）治療薬市場：種類別市場規模予測 2021年-2026年（ルビプロストン、リナクロチド、その他） ・世界の慢性特発性便秘（CIC）治療薬市場：用途別市場規模 2015年-2020年（病院・診療所、外来外科センター、介護センター、その他） ・世界の慢性特発性便秘（CIC）治療薬市場：用途別市場規模予測 2021年-2026年（病院・診療所、外来外科センター、介護センター、その他） ・北米の慢性特発性便秘（CIC）治療薬市場分析：米国、カナダ ・ヨーロッパの慢性特発性便秘（CIC）治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの慢性特発性便秘（CIC）治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の慢性特発性便秘（CIC）治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの慢性特発性便秘（CIC）治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Actavis、Chugai Pharmaceutical、Ferring International Center、Synergy Pharmaceuticals、Pfizer、GlaxoSmithKline、Roche Holding、Sanofi、Bayer、Salix Pharmaceuticals、Sucampo Pharmaceuticals、Ironwood Pharmaceuticals、Progenics Pharmaceuticals ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論

Chronic idiopathic constipation (CIC) is a health condition in which a person experiences chronic symptoms of constipation, yet no visible cause can be identified through standard diagnostic testing. The term idiopathic is used because it means there is no known cause. CIC includes symptoms of difficult, infrequent, or incomplete bowel movements.

Market Analysis and Insights: Global Chronic Idiopathic Constipation (CIC) Drugs Market
The global Chronic Idiopathic Constipation (CIC) Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Chronic Idiopathic Constipation (CIC) Drugs Scope and Market Size
Chronic Idiopathic Constipation (CIC) Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Chronic Idiopathic Constipation (CIC) Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Chronic Idiopathic Constipation (CIC) Drugs market is segmented into
Lubiprostone
Linaclotide
Others

Segment by Application, the Chronic Idiopathic Constipation (CIC) Drugs market is segmented into
Hospitals & Clinics
Ambulatory Surgical Centres
Long Term Care Centres
Others

Regional and Country-level Analysis
The Chronic Idiopathic Constipation (CIC) Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Chronic Idiopathic Constipation (CIC) Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Chronic Idiopathic Constipation (CIC) Drugs Market Share Analysis
Chronic Idiopathic Constipation (CIC) Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Chronic Idiopathic Constipation (CIC) Drugs business, the date to enter into the Chronic Idiopathic Constipation (CIC) Drugs market, Chronic Idiopathic Constipation (CIC) Drugs product introduction, recent developments, etc.

The major vendors covered:
Actavis
Chugai Pharmaceutical
Ferring International Center
Synergy Pharmaceuticals
Pfizer
GlaxoSmithKline
Roche Holding
Sanofi
Bayer
Salix Pharmaceuticals
Sucampo Pharmaceuticals
Ironwood Pharmaceuticals
Progenics Pharmaceuticals

レポート目次

---

1 Study Coverage
1.1 Chronic Idiopathic Constipation (CIC) Drugs Product Introduction
1.2 Market Segments
1.3 Key Chronic Idiopathic Constipation (CIC) Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Chronic Idiopathic Constipation (CIC) Drugs Market Size Growth Rate by Type
1.4.2 Lubiprostone
1.4.3 Linaclotide
1.4.4 Others
1.5 Market by Application
1.5.1 Global Chronic Idiopathic Constipation (CIC) Drugs Market Size Growth Rate by Application
1.5.2 Hospitals & Clinics
1.5.3 Ambulatory Surgical Centres
1.5.4 Long Term Care Centres
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Chronic Idiopathic Constipation (CIC) Drugs Market Size, Estimates and Forecasts
2.1.1 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue 2015-2026
2.1.2 Global Chronic Idiopathic Constipation (CIC) Drugs Sales 2015-2026
2.2 Global Chronic Idiopathic Constipation (CIC) Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Chronic Idiopathic Constipation (CIC) Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Chronic Idiopathic Constipation (CIC) Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Chronic Idiopathic Constipation (CIC) Drugs Competitor Landscape by Players
3.1 Chronic Idiopathic Constipation (CIC) Drugs Sales by Manufacturers
3.1.1 Chronic Idiopathic Constipation (CIC) Drugs Sales by Manufacturers (2015-2020)
3.1.2 Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Chronic Idiopathic Constipation (CIC) Drugs Revenue by Manufacturers
3.2.1 Chronic Idiopathic Constipation (CIC) Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Chronic Idiopathic Constipation (CIC) Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Chronic Idiopathic Constipation (CIC) Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Chronic Idiopathic Constipation (CIC) Drugs Revenue in 2019
3.2.5 Global Chronic Idiopathic Constipation (CIC) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Chronic Idiopathic Constipation (CIC) Drugs Price by Manufacturers
3.4 Chronic Idiopathic Constipation (CIC) Drugs Manufacturing Base Distribution, Product Types
3.4.1 Chronic Idiopathic Constipation (CIC) Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Chronic Idiopathic Constipation (CIC) Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Chronic Idiopathic Constipation (CIC) Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Chronic Idiopathic Constipation (CIC) Drugs Market Size by Type (2015-2020)
4.1.1 Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Type (2015-2020)
4.1.2 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Type (2015-2020)
4.1.3 Chronic Idiopathic Constipation (CIC) Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Chronic Idiopathic Constipation (CIC) Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Chronic Idiopathic Constipation (CIC) Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Chronic Idiopathic Constipation (CIC) Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Chronic Idiopathic Constipation (CIC) Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Chronic Idiopathic Constipation (CIC) Drugs Market Size by Application (2015-2020)
5.1.1 Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Application (2015-2020)
5.1.2 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Application (2015-2020)
5.1.3 Chronic Idiopathic Constipation (CIC) Drugs Price by Application (2015-2020)
5.2 Chronic Idiopathic Constipation (CIC) Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Chronic Idiopathic Constipation (CIC) Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Chronic Idiopathic Constipation (CIC) Drugs Price Forecast by Application (2021-2026)

6 North America
6.1 North America Chronic Idiopathic Constipation (CIC) Drugs by Country
6.1.1 North America Chronic Idiopathic Constipation (CIC) Drugs Sales by Country
6.1.2 North America Chronic Idiopathic Constipation (CIC) Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Chronic Idiopathic Constipation (CIC) Drugs Market Facts & Figures by Type
6.3 North America Chronic Idiopathic Constipation (CIC) Drugs Market Facts & Figures by Application

7 Europe
7.1 Europe Chronic Idiopathic Constipation (CIC) Drugs by Country
7.1.1 Europe Chronic Idiopathic Constipation (CIC) Drugs Sales by Country
7.1.2 Europe Chronic Idiopathic Constipation (CIC) Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Chronic Idiopathic Constipation (CIC) Drugs Market Facts & Figures by Type
7.3 Europe Chronic Idiopathic Constipation (CIC) Drugs Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs by Region
8.1.1 Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Sales by Region
8.1.2 Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Market Facts & Figures by Type
8.3 Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Market Facts & Figures by Application

9 Latin America
9.1 Latin America Chronic Idiopathic Constipation (CIC) Drugs by Country
9.1.1 Latin America Chronic Idiopathic Constipation (CIC) Drugs Sales by Country
9.1.2 Latin America Chronic Idiopathic Constipation (CIC) Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Chronic Idiopathic Constipation (CIC) Drugs Market Facts & Figures by Type
9.3 Central & South America Chronic Idiopathic Constipation (CIC) Drugs Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs by Country
10.1.1 Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Sales by Country
10.1.2 Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Market Facts & Figures by Application

11 Company Profiles
11.1 Actavis
11.1.1 Actavis Corporation Information
11.1.2 Actavis Description and Business Overview
11.1.3 Actavis Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Actavis Chronic Idiopathic Constipation (CIC) Drugs Products Offered
11.1.5 Actavis Related Developments
11.2 Chugai Pharmaceutical
11.2.1 Chugai Pharmaceutical Corporation Information
11.2.2 Chugai Pharmaceutical Description and Business Overview
11.2.3 Chugai Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Chugai Pharmaceutical Chronic Idiopathic Constipation (CIC) Drugs Products Offered
11.2.5 Chugai Pharmaceutical Related Developments
11.3 Ferring International Center
11.3.1 Ferring International Center Corporation Information
11.3.2 Ferring International Center Description and Business Overview
11.3.3 Ferring International Center Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Ferring International Center Chronic Idiopathic Constipation (CIC) Drugs Products Offered
11.3.5 Ferring International Center Related Developments
11.4 Synergy Pharmaceuticals
11.4.1 Synergy Pharmaceuticals Corporation Information
11.4.2 Synergy Pharmaceuticals Description and Business Overview
11.4.3 Synergy Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Synergy Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Products Offered
11.4.5 Synergy Pharmaceuticals Related Developments
11.5 Pfizer
11.5.1 Pfizer Corporation Information
11.5.2 Pfizer Description and Business Overview
11.5.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Pfizer Chronic Idiopathic Constipation (CIC) Drugs Products Offered
11.5.5 Pfizer Related Developments
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Corporation Information
11.6.2 GlaxoSmithKline Description and Business Overview
11.6.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.6.4 GlaxoSmithKline Chronic Idiopathic Constipation (CIC) Drugs Products Offered
11.6.5 GlaxoSmithKline Related Developments
11.7 Roche Holding
11.7.1 Roche Holding Corporation Information
11.7.2 Roche Holding Description and Business Overview
11.7.3 Roche Holding Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Roche Holding Chronic Idiopathic Constipation (CIC) Drugs Products Offered
11.7.5 Roche Holding Related Developments
11.8 Sanofi
11.8.1 Sanofi Corporation Information
11.8.2 Sanofi Description and Business Overview
11.8.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Sanofi Chronic Idiopathic Constipation (CIC) Drugs Products Offered
11.8.5 Sanofi Related Developments
11.9 Bayer
11.9.1 Bayer Corporation Information
11.9.2 Bayer Description and Business Overview
11.9.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Bayer Chronic Idiopathic Constipation (CIC) Drugs Products Offered
11.9.5 Bayer Related Developments
11.10 Salix Pharmaceuticals
11.10.1 Salix Pharmaceuticals Corporation Information
11.10.2 Salix Pharmaceuticals Description and Business Overview
11.10.3 Salix Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Salix Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Products Offered
11.10.5 Salix Pharmaceuticals Related Developments
11.1 Actavis
11.1.1 Actavis Corporation Information
11.1.2 Actavis Description and Business Overview
11.1.3 Actavis Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Actavis Chronic Idiopathic Constipation (CIC) Drugs Products Offered
11.1.5 Actavis Related Developments
11.12 Ironwood Pharmaceuticals
11.12.1 Ironwood Pharmaceuticals Corporation Information
11.12.2 Ironwood Pharmaceuticals Description and Business Overview
11.12.3 Ironwood Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Ironwood Pharmaceuticals Products Offered
11.12.5 Ironwood Pharmaceuticals Related Developments
11.13 Progenics Pharmaceuticals
11.13.1 Progenics Pharmaceuticals Corporation Information
11.13.2 Progenics Pharmaceuticals Description and Business Overview
11.13.3 Progenics Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Progenics Pharmaceuticals Products Offered
11.13.5 Progenics Pharmaceuticals Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Chronic Idiopathic Constipation (CIC) Drugs Market Estimates and Projections by Region
12.1.1 Global Chronic Idiopathic Constipation (CIC) Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Chronic Idiopathic Constipation (CIC) Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Chronic Idiopathic Constipation (CIC) Drugs Sales Forecast (2021-2026)
12.2.2 North America: Chronic Idiopathic Constipation (CIC) Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Chronic Idiopathic Constipation (CIC) Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Chronic Idiopathic Constipation (CIC) Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Chronic Idiopathic Constipation (CIC) Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Chronic Idiopathic Constipation (CIC) Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Chronic Idiopathic Constipation (CIC) Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Chronic Idiopathic Constipation (CIC) Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Chronic Idiopathic Constipation (CIC) Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Chronic Idiopathic Constipation (CIC) Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Chronic Idiopathic Constipation (CIC) Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Chronic Idiopathic Constipation (CIC) Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Chronic Idiopathic Constipation (CIC) Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Chronic Idiopathic Constipation (CIC) Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Chronic Idiopathic Constipation (CIC) Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Chronic Idiopathic Constipation (CIC) Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Chronic Idiopathic Constipation (CIC) Drugs Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Chronic Idiopathic Constipation (CIC) Drugs Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Chronic Idiopathic Constipation (CIC) Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Chronic Idiopathic Constipation (CIC) Drugs Market Segments
Table 2. Ranking of Global Top Chronic Idiopathic Constipation (CIC) Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Chronic Idiopathic Constipation (CIC) Drugs Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Lubiprostone
Table 5. Major Manufacturers of Linaclotide
Table 6. Major Manufacturers of Others
Table 7. Global Chronic Idiopathic Constipation (CIC) Drugs Market Size Growth Rate by Application 2020-2026 (K Units)
Table 8. Global Chronic Idiopathic Constipation (CIC) Drugs Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 9. Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Regions 2015-2020 (K Units)
Table 10. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Regions (2015-2020)
Table 11. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Manufacturers (2015-2020) (K Units)
Table 13. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Share by Manufacturers (2015-2020)
Table 14. Global Chronic Idiopathic Constipation (CIC) Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Chronic Idiopathic Constipation (CIC) Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Idiopathic Constipation (CIC) Drugs as of 2019)
Table 16. Chronic Idiopathic Constipation (CIC) Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Chronic Idiopathic Constipation (CIC) Drugs Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Chronic Idiopathic Constipation (CIC) Drugs Price (2015-2020) (USD/Unit)
Table 19. Chronic Idiopathic Constipation (CIC) Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Chronic Idiopathic Constipation (CIC) Drugs Product Type
Table 21. Date of International Manufacturers Enter into Chronic Idiopathic Constipation (CIC) Drugs Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Type (2015-2020) (K Units)
Table 24. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Share by Type (2015-2020)
Table 25. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Share by Type (2015-2020)
Table 27. Chronic Idiopathic Constipation (CIC) Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 28. Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Application (2015-2020) (K Units)
Table 29. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Share by Application (2015-2020)
Table 30. North America Chronic Idiopathic Constipation (CIC) Drugs Sales by Country (2015-2020) (K Units)
Table 31. North America Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Country (2015-2020)
Table 32. North America Chronic Idiopathic Constipation (CIC) Drugs Revenue by Country (2015-2020) (US$ Million)
Table 33. North America Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Country (2015-2020)
Table 34. North America Chronic Idiopathic Constipation (CIC) Drugs Sales by Type (2015-2020) (K Units)
Table 35. North America Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Type (2015-2020)
Table 36. North America Chronic Idiopathic Constipation (CIC) Drugs Sales by Application (2015-2020) (K Units)
Table 37. North America Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Application (2015-2020)
Table 38. Europe Chronic Idiopathic Constipation (CIC) Drugs Sales by Country (2015-2020) (K Units)
Table 39. Europe Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Country (2015-2020)
Table 40. Europe Chronic Idiopathic Constipation (CIC) Drugs Revenue by Country (2015-2020) (US$ Million)
Table 41. Europe Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Country (2015-2020)
Table 42. Europe Chronic Idiopathic Constipation (CIC) Drugs Sales by Type (2015-2020) (K Units)
Table 43. Europe Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Type (2015-2020)
Table 44. Europe Chronic Idiopathic Constipation (CIC) Drugs Sales by Application (2015-2020) (K Units)
Table 45. Europe Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Application (2015-2020)
Table 46. Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Sales by Region (2015-2020) (K Units)
Table 47. Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Region (2015-2020)
Table 48. Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Revenue by Region (2015-2020) (US$ Million)
Table 49. Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Region (2015-2020)
Table 50. Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Sales by Type (2015-2020) (K Units)
Table 51. Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Type (2015-2020)
Table 52. Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Sales by Application (2015-2020) (K Units)
Table 53. Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Application (2015-2020)
Table 54. Latin America Chronic Idiopathic Constipation (CIC) Drugs Sales by Country (2015-2020) (K Units)
Table 55. Latin America Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Country (2015-2020)
Table 56. Latin Americaa Chronic Idiopathic Constipation (CIC) Drugs Revenue by Country (2015-2020) (US$ Million)
Table 57. Latin America Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Country (2015-2020)
Table 58. Latin America Chronic Idiopathic Constipation (CIC) Drugs Sales by Type (2015-2020) (K Units)
Table 59. Latin America Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Type (2015-2020)
Table 60. Latin America Chronic Idiopathic Constipation (CIC) Drugs Sales by Application (2015-2020) (K Units)
Table 61. Latin America Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Application (2015-2020)
Table 62. Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Sales by Country (2015-2020) (K Units)
Table 63. Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Country (2015-2020)
Table 64. Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Revenue by Country (2015-2020) (US$ Million)
Table 65. Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Country (2015-2020)
Table 66. Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Sales by Type (2015-2020) (K Units)
Table 67. Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Type (2015-2020)
Table 68. Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Sales by Application (2015-2020) (K Units)
Table 69. Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Application (2015-2020)
Table 70. Actavis Corporation Information
Table 71. Actavis Description and Major Businesses
Table 72. Actavis Chronic Idiopathic Constipation (CIC) Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 73. Actavis Product
Table 74. Actavis Recent Development
Table 75. Chugai Pharmaceutical Corporation Information
Table 76. Chugai Pharmaceutical Description and Major Businesses
Table 77. Chugai Pharmaceutical Chronic Idiopathic Constipation (CIC) Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Chugai Pharmaceutical Product
Table 79. Chugai Pharmaceutical Recent Development
Table 80. Ferring International Center Corporation Information
Table 81. Ferring International Center Description and Major Businesses
Table 82. Ferring International Center Chronic Idiopathic Constipation (CIC) Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Ferring International Center Product
Table 84. Ferring International Center Recent Development
Table 85. Synergy Pharmaceuticals Corporation Information
Table 86. Synergy Pharmaceuticals Description and Major Businesses
Table 87. Synergy Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Synergy Pharmaceuticals Product
Table 89. Synergy Pharmaceuticals Recent Development
Table 90. Pfizer Corporation Information
Table 91. Pfizer Description and Major Businesses
Table 92. Pfizer Chronic Idiopathic Constipation (CIC) Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Pfizer Product
Table 94. Pfizer Recent Development
Table 95. GlaxoSmithKline Corporation Information
Table 96. GlaxoSmithKline Description and Major Businesses
Table 97. GlaxoSmithKline Chronic Idiopathic Constipation (CIC) Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. GlaxoSmithKline Product
Table 99. GlaxoSmithKline Recent Development
Table 100. Roche Holding Corporation Information
Table 101. Roche Holding Description and Major Businesses
Table 102. Roche Holding Chronic Idiopathic Constipation (CIC) Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Roche Holding Product
Table 104. Roche Holding Recent Development
Table 105. Sanofi Corporation Information
Table 106. Sanofi Description and Major Businesses
Table 107. Sanofi Chronic Idiopathic Constipation (CIC) Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Sanofi Product
Table 109. Sanofi Recent Development
Table 110. Bayer Corporation Information
Table 111. Bayer Description and Major Businesses
Table 112. Bayer Chronic Idiopathic Constipation (CIC) Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Bayer Product
Table 114. Bayer Recent Development
Table 115. Salix Pharmaceuticals Corporation Information
Table 116. Salix Pharmaceuticals Description and Major Businesses
Table 117. Salix Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 118. Salix Pharmaceuticals Product
Table 119. Salix Pharmaceuticals Recent Development
Table 120. Sucampo Pharmaceuticals Corporation Information
Table 121. Sucampo Pharmaceuticals Description and Major Businesses
Table 122. Sucampo Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 123. Sucampo Pharmaceuticals Product
Table 124. Sucampo Pharmaceuticals Recent Development
Table 125. Ironwood Pharmaceuticals Corporation Information
Table 126. Ironwood Pharmaceuticals Description and Major Businesses
Table 127. Ironwood Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Ironwood Pharmaceuticals Product
Table 129. Ironwood Pharmaceuticals Recent Development
Table 130. Progenics Pharmaceuticals Corporation Information
Table 131. Progenics Pharmaceuticals Description and Major Businesses
Table 132. Progenics Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 133. Progenics Pharmaceuticals Product
Table 134. Progenics Pharmaceuticals Recent Development
Table 135. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Forecast by Regions (2021-2026) (K Units)
Table 136. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 137. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 138. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 139. North America: Chronic Idiopathic Constipation (CIC) Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 140. North America: Chronic Idiopathic Constipation (CIC) Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 141. Europe: Chronic Idiopathic Constipation (CIC) Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 142. Europe: Chronic Idiopathic Constipation (CIC) Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 143. Asia Pacific: Chronic Idiopathic Constipation (CIC) Drugs Sales Forecast by Region (2021-2026) (K Units)
Table 144. Asia Pacific: Chronic Idiopathic Constipation (CIC) Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 145. Latin America: Chronic Idiopathic Constipation (CIC) Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 146. Latin America: Chronic Idiopathic Constipation (CIC) Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 147. Middle East and Africa: Chronic Idiopathic Constipation (CIC) Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 148. Middle East and Africa: Chronic Idiopathic Constipation (CIC) Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 149. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 150. Key Challenges
Table 151. Market Risks
Table 152. Main Points Interviewed from Key Chronic Idiopathic Constipation (CIC) Drugs Players
Table 153. Chronic Idiopathic Constipation (CIC) Drugs Customers List
Table 154. Chronic Idiopathic Constipation (CIC) Drugs Distributors List
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
List of Figures
Figure 1. Chronic Idiopathic Constipation (CIC) Drugs Product Picture
Figure 2. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Lubiprostone Product Picture
Figure 4. Linaclotide Product Picture
Figure 5. Others Product Picture
Figure 6. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Application in 2020 & 2026
Figure 7. Hospitals & Clinics
Figure 8. Ambulatory Surgical Centres
Figure 9. Long Term Care Centres
Figure 10. Others
Figure 11. Chronic Idiopathic Constipation (CIC) Drugs Report Years Considered
Figure 12. Global Chronic Idiopathic Constipation (CIC) Drugs Market Size 2015-2026 (US$ Million)
Figure 13. Global Chronic Idiopathic Constipation (CIC) Drugs Sales 2015-2026 (K Units)
Figure 14. Global Chronic Idiopathic Constipation (CIC) Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Region (2015-2020)
Figure 16. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Region in 2019
Figure 17. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Region (2015-2020)
Figure 18. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Region in 2019
Figure 19. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Chronic Idiopathic Constipation (CIC) Drugs Revenue in 2019
Figure 21. Chronic Idiopathic Constipation (CIC) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Type (2015-2020)
Figure 23. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Type in 2019
Figure 24. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Type (2015-2020)
Figure 25. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Type in 2019
Figure 26. Global Chronic Idiopathic Constipation (CIC) Drugs Market Share by Price Range (2015-2020)
Figure 27. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Application (2015-2020)
Figure 28. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Application in 2019
Figure 29. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Application (2015-2020)
Figure 30. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Application in 2019
Figure 31. North America Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 32. North America Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Country in 2019
Figure 34. North America Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Country in 2019
Figure 35. U.S. Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 36. U.S. Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 38. Canada Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Chronic Idiopathic Constipation (CIC) Drugs Market Share by Type in 2019
Figure 40. North America Chronic Idiopathic Constipation (CIC) Drugs Market Share by Application in 2019
Figure 41. Europe Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 42. Europe Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Country in 2019
Figure 44. Europe Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Country in 2019
Figure 45. Germany Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 46. Germany Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 48. France Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 50. U.K. Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 52. Italy Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 54. Russia Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Chronic Idiopathic Constipation (CIC) Drugs Market Share by Type in 2019
Figure 56. Europe Chronic Idiopathic Constipation (CIC) Drugs Market Share by Application in 2019
Figure 57. Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 58. Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Region in 2019
Figure 60. Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Region in 2019
Figure 61. China Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 62. China Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 64. Japan Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 66. South Korea Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 68. India Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 70. Australia Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 72. Taiwan Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 74. Indonesia Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 76. Thailand Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 78. Malaysia Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 80. Philippines Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 82. Vietnam Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Market Share by Type in 2019
Figure 84. Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Market Share by Application in 2019
Figure 85. Latin America Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 86. Latin America Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Country in 2019
Figure 88. Latin America Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Country in 2019
Figure 89. Mexico Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 90. Mexico Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 92. Brazil Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 94. Argentina Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Chronic Idiopathic Constipation (CIC) Drugs Market Share by Type in 2019
Figure 96. Latin America Chronic Idiopathic Constipation (CIC) Drugs Market Share by Application in 2019
Figure 97. Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 98. Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Country in 2019
Figure 101. Turkey Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 102. Turkey Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 104. Saudi Arabia Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 106. U.A.E Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Market Share by Type in 2019
Figure 108. Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Market Share by Application in 2019
Figure 109. North America Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 110. North America Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Europe Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 112. Europe Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 114. Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Latin America Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 116. Latin America Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 118. Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Porter's Five Forces Analysis
Figure 120. Channels of Distribution
Figure 121. Distributors Profiles
Figure 122. Bottom-up and Top-down Approaches for This Report
Figure 123. Data Triangulation
Figure 124. Key Executives Interviewed

---